Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive ...

This study is an offshoot of a broader 2022 clinical trial published in the New England Journal of Medicine, which found weekly doses of tirzepatide led to weight loss in up to 22.5% of participants.

This analysis included 690 tirzepatide-adherent participants (65% female, 35% male) with a mean age of 49 years, a mean weight of 107 kg, and a mean BMI of 38.6 kg/m 2 who were chosen from the ...

UTMB Health study says erectile dysfunction meds associated with reductions — but not where you might think 😅 Ahmed Humble , Digital Content Producer Published: November 19, 2024 at 11:38 AM ...

Researchers conducted a three-year-long study that involved about 500,000 men aged 40 and up and found health improvements in men who took drugs for erectile dysfunction. 24/7 Live Houston ...

Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for, respectively, diabetes and weight loss, reduced the risk of heart failure outcomes by 38% compared to placebo ...

BOSTON - A new study in the journal Neurology finds that popular drugs used to treat erectile dysfunction, like Viagra, could help reduce the risk of Alzheimer's disease. Researchers in the U.K ...